Salt Lake City, UT (September 8, 2022) Today, Chief Scientific Officer Dr. David Vollmer announced that the journal Cosmetics
has accepted the clinical study of 4Life äKwä®
Skincare System for publication.
4Life’s clinical study will appear in a special issue of Cosmetics: Novel Cosmetic Ingredients, Formulations and Devices.
Dr. Lawry Han, Vice President of Product Development: “Cosmetics
is a highly reputable journal in the field of cosmetics science and technology. This marks our first published clinical study of 4Life skincare products and represents another step in our continuous efforts to scientifically validate 4Life products.”
The clinical study evaluated the effectiveness of 4Life’s äKwä Skincare System to improve facial skin health and beauty. Twenty-six healthy adults, both female and male, aged 18−54, and of all skin types and tones, participated in the study as part of either the active or control group for 30 days.
Senior Vice President of Marketing Kelly Bellerose: “Skin dryness, fine lines and wrinkles, red spots, red vasculature, and porphyrin count are common indicators of skin health and beauty. In this study, our äKwä Skincare System users expressed significant improvement in facial moisture, red spot count, red vascular count, and porphyrin in comparison to the control group.”
4Life, the Immune System Company®
, and the first to bring transfer factor research to market, has offices in dozens of countries to serve the company’s worldwide customers.
For more information:
Vice President Corporate Communications